Clinical Trial Update: A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

View source ↗

Summary

A non-interventional registration study evaluating camrelizumab or famitinib regimens (monotherapy or combination) for metastatic or recurrent cervical cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)
• Famitinib (Famitinib)

Snippet

Sponsor: Qi Zhou | Conditions: Cervical Cancer Metastatic, Cervical Cancer Recurrent | Status: NOT_YET_RECRUITING